DOI: 10.1055/s-00023610

Drug Research

eFirst

Publication Date: 24 September 2025

Original Article

  • Dharavath, Narendhar; Porika, Mahendar; Tippani, Radhika; Kola, Anand Kishore; Murigingayil Joseph, Tomy; Shevtsov, Maxim; Sonawane, Shirish H:

    Characterization and Therapeutic Assessment of Phytomediated Silver Nanoparticles Produced from the Stem Bark of Bombax ceiba

    Supplementary Material (PDF)

    • Review

  • Chougule, Krutuja R.; Patil, Archana S.; Patil, Swapnil:

    Lasmiditan in Migraine Management: An Advanced Review of Its Pharmacological Paradigm, Clinical Applications, Safety Considerations, Drug Interaction Spectrum, and Regulatory Approval

    • Publication Date: 08 September 2025

    Original Article

  • Salimi, Ahmad; Pourgholi, Mahshad; Khezri, Saleh; Haddadi, Shadi; Asgari, Bahare:

    Sinapic Acid Protects Mortality and Toxicity Induced by N-Ethyl-N-Nitrosourea, a Full Carcinogen Agent, in Mice

    • Review

  • Alves, Erica; Bannimath, Gurupadayya; Prabhakaran, Prabitha:

    Repurposing FDA-Approved Drugs as Fructosamine-3-Kinase Inhibitors: A Mechanistic and Translational Approach to Redox-Driven Cancer Therapy

    • Publication Date: 29 August 2025

    Original Article

  • Gasparova, Zdenka; Bukatova, Stanislava; Dubovicky, Michal:

    Maternal Mirtazapine Selectively Enhances Hippocampal LTP without Reversing Stress-Associated Alterations in Basal Transmission, Short-Term Plasticity, or Open Field Behaviour in Rat Offspring

    • Original Article

  • Mulani, Altaf Osman; Deshmukh, Minal; Jadhav, Vaishali; Chaudhari, Kalyani; Mathew, Ammu Anna; Salunkhe, Shweta:

    Transforming Drug Therapy with Deep Learning: The Future of Personalized Medicine

    • Publication Date: 18 August 2025

    Original Article

  • Ding, Likun; Ma, Ning; Liu, Meiyou; Zhang, Di; Zhang, JuanLi; Fan, Tingting; Wang, Jingwen:

    Pembrolizumab-associated hepatobiliary disorders: a real-world pharmacovigilance study using the FDA Adverse Events Reporting System (FAERS)